<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04712370</url>
  </required_header>
  <id_info>
    <org_study_id>33143/05/19</org_study_id>
    <nct_id>NCT04712370</nct_id>
  </id_info>
  <brief_title>Conventional Caudal Block, Ultrasound Guided Caudal Block and Ultrasound Guided Erector Spinae Block for Pediatric Hip Surgery</brief_title>
  <official_title>Comparison of Conventional Caudal Block, Ultrasound Guided Caudal Block and Ultrasound Guided Erector Spinae Block for Pediatric Hip Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to compare the efficacy and safety of ultrasound guided erector&#xD;
      spinae block , ultrasound guided caudal block and conventional caudal block for pain&#xD;
      management after pediatric hip surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2021</start_date>
  <completion_date type="Anticipated">September 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of pain intensity</measure>
    <time_frame>First 24 hours postoperative</time_frame>
    <description>To evaluate the pain scores by (FLACC) scale. (FLACC) scale will be assessed after surgery over 24 hours where (0 = Relaxed and comfortable, 1-3 = Mild discomfort, 4-6 = Moderate pain ,7-10 = Severe discomfort /pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in mean arterial blood pressure</measure>
    <time_frame>Intraoperative and first 24 hours postoperative</time_frame>
    <description>Mean arterial blood pressure will be recorded before block performance at T0, intraoperatively at 15 and 30 minutes, then every 30 min till the end of surgery and after surgery at T (0, 2, 4, 6, 12, 24 h).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate</measure>
    <time_frame>Intraoperative and first 24 hours postoperative</time_frame>
    <description>Heart rate will be recorded before block performance at T0, intraoperatively at 15 and 30 minutes, then every 30 min till the end of surgery and after surgery at T (0, 2, 4, 6, 12, 24 h).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Analgesic required in the first day after surgery</measure>
    <time_frame>First 24 hours postoperative</time_frame>
    <description>The total dose of intravenous (IV) acetaminophen 15 mg/kg if FLACC scores between 2 and 4 at the first 24 h after surgery, and total dose of tramadol 1 mg/kg (IV) in case of FLACC score &gt; 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first rescue analgesic demand after surgery.</measure>
    <time_frame>First 24 hours postoperative</time_frame>
    <description>measured from the end of surgery till patient require analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate of block</measure>
    <time_frame>Intraoperative duration</time_frame>
    <description>a successful block is defined as absence of significant changes in heart rate following surgical induction. Heart rate increase is not&gt;20% of the basal levels. If the increase is&gt;20%, the block is accepted as unsuccessful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of performing the block</measure>
    <time_frame>Intraoperative duration</time_frame>
    <description>Block performing time is defined as the period between the insertion of the needle and termination of local anesthetic administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>Intraoperative and first 24 hours postoperative</time_frame>
    <description>Hypotension, bradycardia, postoperative nausea, vomiting, urinary retention, prolonged motor block, pruritus and local anesthetic systemic toxicity (LAST).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Conventional Caudal Block</condition>
  <condition>Ultrasound Guided Caudal Block</condition>
  <condition>Ultrasound Guided Erector Spinae Block</condition>
  <condition>Pediatric Hip Surgery</condition>
  <arm_group>
    <arm_group_label>Conventional caudal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients of this group will receive the conventional method (blind technique without ultrasound) of caudal block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound-guided caudal block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients of this group will receive caudal block using ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound guided erector spinae plane Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients of this group will receive ultrasound guided erector spinae plane Block at the level of the transverse process of the second lumbar vertebrae(L2) .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional caudal block</intervention_name>
    <description>Patients of this group will receive (0.5ml/kg) (plain bupivacaine 0.25% injected in the caudal epidural space) by the conventional method (blind technique without ultrasound).</description>
    <arm_group_label>Conventional caudal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided caudal block</intervention_name>
    <description>Using ultrasound, patients of this group will receive (0.5ml/kg) (plain bupivacaine 0.25% injected in the caudal epidural space).</description>
    <arm_group_label>Ultrasound-guided caudal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound guided erector spinae plane Block</intervention_name>
    <description>Under ultrasound guidance, patients of this group will receive (0.5ml/kg) (plain bupivacaine 0.25% injected beneath the erector spinae muscle sheath) at the level of the transverse process of the second lumbar vertebrae(L2).</description>
    <arm_group_label>Ultrasound guided erector spinae plane Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Both sex&#xD;
&#xD;
          -  ASA physical activity I, II&#xD;
&#xD;
          -  Age 4-12 years&#xD;
&#xD;
          -  Admitted for elective hip surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Parents refusal&#xD;
&#xD;
          -  Children with severe systemic disease&#xD;
&#xD;
          -  ASA III or IV&#xD;
&#xD;
          -  Children with previous neurological or spinal anomaly, coagulation disorders&#xD;
&#xD;
          -  History of premature birth&#xD;
&#xD;
          -  Infection at the block injection site&#xD;
&#xD;
          -  History of allergy to local anesthetics&#xD;
&#xD;
          -  Bilateral hip surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eman Hamdy Abu-Shanab, MSc</last_name>
    <phone>+201005518097</phone>
    <email>eman.hamdy@med.tanta.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tanta University Hospitals</name>
      <address>
        <city>Tanta</city>
        <state>ElGharbiaa</state>
        <zip>31527</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eman Hamdy Abu-Shanab</last_name>
      <phone>+201005518097</phone>
      <email>eman.hamdy@med.tanta.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>January 16, 2021</last_update_submitted>
  <last_update_submitted_qc>January 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Eman Hamdy Abu-Shanab</investigator_full_name>
    <investigator_title>Principal Investigator and Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be available upon reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>For 1 year after the end of the study</ipd_time_frame>
    <ipd_access_criteria>The principal investigator will review requests</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

